# FDA Inspection 912526 - Biomat USA, Inc - February 04, 2015

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d39dc4f9-3f77-4f0d-b737-fecf7f645e0c
Source feed: FDA_Inspections

> FDA Inspection 912526 for Biomat USA, Inc on February 04, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 912526
- Company Name: Biomat USA, Inc
- Inspection Date: 2015-02-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253778 - 2024-10-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4fab8994-e906-40c3-a724-cf0cd0dd78ee)
- [FDA Inspection 1253778 - 2024-10-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/60bae5b5-7ed1-4411-95b7-6a5ffaa4017d)
- [FDA Inspection 1005674 - 2017-02-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/82636e11-2464-4a63-a53b-6e722a714f41)
- [FDA Inspection 808445 - 2012-12-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b998c594-4649-4da5-bfce-04ec5a667ef1)
- [FDA Inspection 706602 - 2011-01-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/0a63e766-6233-49b7-9e14-882ab54dd92a)

Company: https://www.keypedia.com/companies/biomat-usa-inc/b6273141-77b1-4ec0-948b-501e4d7ef2b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d